中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:( Rongbiao YING)

1.Expression of survivin and caspase-3 in gastric cancer and its clinical significance

Rongbiao YING ; Jun FENG ; Jianjun LI ; Jun YAO

China Oncology 2010;20(1):17-21

2.Analysis of the curative effect of minimally invasive surgery in the treatment of rectal cancer

Zhiping WEI ; Rongbiao YING ; Jun YAO ; Zhe HU

Chinese Journal of Primary Medicine and Pharmacy 2017;24(12):1782-1785

3.Pedigree screening of a Chinese multiple endocrine neoplasia type 2A family and prophylactic total thy-roidectomy

Jianqiang ZHAO ; Xiaoping QI ; Jianlin LOU ; Zhenguang CHEN ; Liang GUO ; Xiuhua YU ; Bo CHEN ; Hangyang JIN ; Rongbiao YING ; Kejing WANG ; Chun HAN ; Xianning ZHANG

Journal of Endocrine Surgery 2014;(2):145-149

4.Changes of serum fatty acid synthase, carcinoembryonic antigen and carbohydrate antigen 72-4 in patients with gastric cancer and its clinical diagnostic value

Zhiping WEI ; Rongbiao YING ; Yingyuan XIE ; Jun YAO ; Zhe HU

Journal of Chinese Physician 2017;19(9):1358-1360,1365

5.Multiple endocrine neoplasia type 2A caused by a p.C618R RET proto-oncogene mutation in a Chinese pedigree.

Zhenguang CHEN ; Xiaoping QI ; Jun FEI ; Xiuhua YU ; Yan ZHAO ; Jianqiang ZHAO ; Hangyang JIN ; Jinquan WANG ; Rongbiao YING ; Xianning ZHANG

Chinese Journal of Medical Genetics 2014;31(3):348-351

6.Effect of a novel EZH2 inhibitor GSK126 on prostate cancer cells.

Weiren LIN ; Yatian CHEN ; Linghui ZENG ; Rongbiao YING ; Feng ZHU

Journal of Zhejiang University. Medical sciences 2016;45(4):356-363

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO